Device Firms Dig In Against Baucus Fee, Despite Class I, Revenue Exceptions
This article was originally published in The Gray Sheet
Executive Summary
The device industry lobbying machine has accelerated in opposition to Sen. Max Baucus' plan for a $40 billion fee on manufacturers in the lead up to Finance Committee health reform mark-up sessions this week